
Y-mAbs Therapeutics, Inc. YMAB
Trading inactive
Analyst Consensus
Price Objectif
Analyst historical
Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
---|---|---|---|---|---|
Etzer Darout | BMO Capital | 15.06 $ | 24 $ | 8.94 % | 11/11/2024 |
Nicole Germino | Truist Financial | 12.33 $ | 21 $ | 8.67 % | 28/06/2024 |
Robert Burns | H.C. Wainwright | 12.87 $ | 22 $ | 9.13 % | 10/05/2024 |
Etzer Darout | BMO Capital | 14.56 $ | 26 $ | 11.44 % | 05/04/2024 |
YMAB)to Outperform | Wedbush | 9.895 $ | 13 $ | 3.11 % | 10/05/2023 |